Additional file 1 of Risk of cardiovascular events after an exacerbation of chronic obstructive pulmonary disease: results from the EXACOS-CV cohort study using the PHARMO Data Network in the Netherlands

Additional file 1: Figure S1. Flowchart of patient selection. Table S1. Codes used for identification of outcomes, and covariate. Table S2. Outcomes during follow-up in the study population of newly diagnosed COPD patients. Table S3. Crude incidence rates for the first outcome of interest (non-fatal severe CV events or all-cause death) in exposed periods in the 365 days following an exacerbation of COPD (moderate or severe, moderate, severe, first, second, and third) and in the unexposed period.